No Data
Xi'An International Medical Investment (000516.SZ): has cumulatively repurchased 0.4865% of shares.
Gelonghui, April 2 - Xi'An International Medical Investment (000516.SZ) announced that as of March 31, 2025, the company has cumulatively repurchased 10,997,100 shares through the centralized bidding trading system of the Shenzhen Stock Exchange, accounting for 0.4865% of the company's current total equity, with a highest Fill Price of 5.618 yuan/share and a lowest Fill Price of 4.61 yuan/share, totaling an amount of 57.4268 million yuan (excluding transaction costs).
Xi'An International Medical Investment (000516.SZ): The local deployment of the related Medical Asia Vets models has been completed.
Gelonghui reported on March 24 that Xi'An International Medical Investment (000516.SZ) stated on the investor interaction platform that the company has always paid attention to cutting-edge technology. Under the strict guarantee of data privacy and Cybersecurity, the relevant Medical Asia Vets models have been locally deployed, achieving connectivity with core Business systems such as HIS (Hospital Information System) and EMR (Electronic Medical Record System).
Xi'An International Medical Investment (000516.SZ): Currently, the cooperation with Alibaba is mainly focused on the technical level.
On March 24, the company Xi'An International Medical Investment (000516.SZ) stated on the investor interaction platform that its collaboration with Alibaba is currently focused on the technical level, specifically including the use of Alibaba's proprietary cloud solutions, as well as technical support and maintenance services for proprietary cloud version upgrades, resource expansion, and other aspects. The company has always maintained a focus on cutting-edge technologies, and under the strict guarantee of data privacy and Cybersecurity, it has completed the local deployment of related Medical intelligent models, achieving connectivity with core Business systems such as HIS (Hospital Information System) and EMR (Electronic Medical Record System).
Xi'An International Medical Investment (000516.SZ) has spent 57.427 million yuan to repurchase 10.9971 million shares.
Xi'An International Medical Investment (000516.SZ) issued an announcement that as of January 31, 2025, the company has accumulated through Shenzhen...
International Medicine: 2024 performance forecast
Xi'An International Medical Investment (000516.SZ): The proton therapy system is currently in the precision installation, debugging, and acceptance phase.
On January 3, Gelonghui reported that Xi'An International Medical Investment (000516.SZ) stated on the investor interactive platform that the Xi'An International Medical Investment is constructing a proton therapy center project. Currently, the proton therapy system has entered the precision installation, debugging, and acceptance phase, and it is expected to be completed and put into use by the end of 2025. Additionally, the company still has some land resources awaiting development. In the future, the company will further expand new business sectors such as life health management and integrated medical services based on the existing high-level Medical platform.
